The SHORE study, in collaboration with Jefferson Health, will assess the feasibility of home-based, continuous monitoring of cough and lung sounds including wheeze and rhonchi following COPD exacerbations. Enrollment started in January. PHILADELPHIA, PA / ACCESS Newswire / January 28, 2026 / Strados Labs, a medical technology company advancing respiratory care through wearable…
Read More
Strados Labs Collaborates with Rutgers Robert Wood Johnson Medical School, RWJBarnabas Health to Evaluate Wearable Respiratory Monitoring Cystic Fibrosis The pilot study explores the RESP® Biosensor’s potential to allow for low-effort home monitoring in patients with acute and chronic cystic fibrosis. by Strados Labs | Aug 28, 2025 | Press Releases Philadelphia,…
Read More
Strados Labs Introduces Grant Initiative to Accelerate Research into Continuous Lung Sound Monitoring The new program provides eligible research studies with in-kind support for the use of the RESP® Biosensor system. by Strados Labs | Mar 25, 2025 | Press Releases Philadelphia, PA, March 20, 2025 – Strados Labs, a medical technology company, is…
Read More
Strados Labs Collaborates with Beth Israel Deaconess Medical Center for Innovative Study in Pulmonary Edema The study will evaluate continuous lung sound monitoring for the early detection of pulmonary edema and prevention of complications in critically ill ICU patients. by Strados Labs | Feb 20, 2025 | Press Releases Philadelphia, PA, February 20, 2025 —…
Read More
Delve Health Partners with Strados Labs to Enhance Remote Patient Monitoring in Clinical Trials See more here
Read More
Strados Labs announces successful completion of pediatric asthma study See more here
Read More
Strados Labs Announces Pediatric Asthma Study to Validate its Wearable Device in Children with Wheeze Strados Labs’ RESP™ Biosensor is currently being used in a clinical trial at Lurie Children’s to determine if the technology can accurately detect wheezing and other symptoms of asthma exacerbation in children. See more…
Read More
Clario and Strados Labs partner to bring new pulmonary endpoints to respiratory clinical trials Clario has partnered with Strados Labs to offer its customers the RESP™ Biosensor System, an advanced technological innovation for the at-home capture of lung sounds. The revolutionary device enables Clario to support the capture of additional…
Read More
Strados Labs Forms Collaboration with Boehringer Ingelheim for its Idiopathic Pulmonary Fibrosis (IPF) Pilot Study Starting in early 2023 the biopharmaceutical company will use the Strados RESP™ Biosensor to remotely monitor cough and crackles in patients at home. See more here
Read More